Potassium Chloride

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Potassium Chloride
Generic name: POTASSIUM CHLORIDE
Manufacturer: Bryant Ranch Prepack
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 7a220e87-ff72-417b-bc45-90a37b7f2aa6
SPL ID: d914b262-7244-4d71-980d-e5508f994eba
Version: 102
Effective date: 2024-05-21
Source export date: 2026-08-17
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-08-17/2761da4658ad131439428ba873b36a73954aaa035ff81deb66240a9db091dbf8/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: ca19d5b1416b6b66a9d383bfdc77d90e91adfeefe16ffcc1ac6b06ceb90d8d73
Import run: 20260818T065550Z
Imported at: 2026-08-18 08:11:59

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 18 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	210200	derived:openfda.application_number
application number		ANDA210200	openfda.application_number
brand name		Potassium Chloride	openfda.brand_name
generic name		POTASSIUM CHLORIDE	openfda.generic_name
manufacturer name		Bryant Ranch Prepack	openfda.manufacturer_name
ndc	package	72162-2310-4	openfda.package_ndc
ndc	package	72162-2310-1	openfda.package_ndc
ndc	package	72162-2310-2	openfda.package_ndc
ndc	package	72162-2310-3	openfda.package_ndc
ndc	product	72162-2310	openfda.product_ndc
ndc11	package	72162231002	derived:openfda.package_ndc
ndc11	package	72162231001	derived:openfda.package_ndc
ndc11	package	72162231003	derived:openfda.package_ndc
ndc11	package	72162231004	derived:openfda.package_ndc
rxcui		1867544	openfda.rxcui
spl id		d914b262-7244-4d71-980d-e5508f994eba	id
spl set id		7a220e87-ff72-417b-bc45-90a37b7f2aa6	set_id
unii		660YQ98I10	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings and cautions

5 WARNINGS AND PRECAUTIONS • Gastrointestinal Irritation: Dilute before use, take with meals ( 5.1 ) 5.1 Gastrointestinal Irritation May cause gastrointestinal irritation. Increased dilution of the solution and taking with meals may reduce gastrointestinal irritation [see Dosage and Administration (2.1) ] .

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

6 ADVERSE REACTIONS The most common adverse reactions to oral potassium salts are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. Most common adverse reactions are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Virtus Pharmaceuticals, LLC at 1-888-848-3593 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.